Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis

Amyloid

Volumn 24, Issue 2, 2017, Pages 123-130

  Kuroda, Takeshi ^a   Tanabe, Naohito ^b   Hasegawa, Eriko ^a   Wakamatsu, Ayako ^a   Nozawa, Yukiko ^a   Sato, Hiroe ^a   Nakatsue, Takeshi ^a   Wada, Yoko ^a   Ito, Yumi ^a   Imai, Naofumi ^a   Ueno, Mitsuhiro ^c   Nakano, Masaaki ^d   Narita, Ichiei ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b UNIVERSITY OF NIIGATA PREFECTURE   (Japan)

^c JOETSU UNIVERSITY OF EDUCATION   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

Author keywords

AA amyloidosis; AL amyloidosis; renal biopsy; renal function; rheumatoid arthritis

Indexed keywords

ALBUMIN; AMYLOID; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN; URIC ACID; SERUM AMYLOID A;

AA AMYLOIDOSIS; ADULT; AGE; AL AMYLOIDOSIS; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DIURETIC THERAPY; ERYTHROCYTE COUNT; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; HEMATOCRIT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY TISSUE; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MESANGIUM; MIDDLE AGED; NORMAL VALUE; PRIORITY JOURNAL; PROGNOSIS; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN URINE LEVEL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RHEUMATOID ARTHRITIS; SEX; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; AGED; BIOPSY; BLOOD PRESSURE; COMPLICATION; GLOMERULUS FILTRATION RATE; KIDNEY; KIDNEY FUNCTION TEST; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROTEINURIA; RHEUMATIC FEVER; URINE;

AGED; BIOPSY; BLOOD PRESSURE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOGLOBULIN LIGHT-CHAIN AMYLOIDOSIS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROTEINURIA; RHEUMATIC FEVER; SERUM AMYLOID A PROTEIN;

EID: 85020757742     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506129.2017.1338565     Document Type: Article

References (28)

1. Young A, Koduri G, Batley M, et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford). 2007;46:350–357.
2. Baecklund E, Iliadou A, Askling J, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006;54:692–701.
3. Maradit-Kremers H, Nicola PJ, Crowson CS, et al. Cardiovascular death in rheumatoid arthritis:a population-based study. Arthritis Rheum. 2005;52:722–732.
4. Watson DJ, Rhodes T, Guess HA., All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol. 2003;30:1196–1202.
5. Gertz MA, Kyle RA., Secondary systemic amyloidosis:response and survival in 64 patients. Medicine (Baltimore). 1991;70:246–256.
6. Gillmore JD, Lovat L, Persey MR, et al. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid protein. Lancet. 2001;358:24–29.
7. Husby G, Husebekk A, Skogen B, et al. Serum amyloid A (SAA)-the precursor of protein AA in secondary amyloidosis. Adv Exp Med Biol. 1988;243:185–192.
8. Cunnane G, Whitehead AS., Amyloid precursors and amyloidosis in rheumatoid arthritis. Baillieres Best Pract Res Clin Rheumatol. 1999;13:615–628.
9. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1977;337:898–909.
10. Kuroda T, Tanabe N, Kobayashi D, et al. between clinical parameters and amyloid-positive area in gastroduodenal biopsy in reactive amyloidosis associated with rheumatoid arthritis. Rheumatol Int. 2012;32:3155–3162.
11. Kuroda T, Tanabe N, Kobayashi D, et al. Significant association between renal function and amyloid-positive area in renal biopsy specimens in AL amyloidosis. BMC Nephrol. 2012;13:118.
12. Arnett FC, Edworthy SM, Bloch DA, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–324.
13. Imai E, Horio M, Nitta K, et al. Modification of the modification of diet in renal disease (MDRD) study equation for Japan. Am J Kidney Dis. 2007;50:927–937.
14. Suzuki A, Ohosone Y, Obana M, et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol. 1994;21:33–36.
15. Joss N, McLaughlin K, Simpson K, et al. Presentation, survival and prognostic markers in AA amyloidosis. QJM. 2000;93:535–542.
16. Tanaka F, Migita K, Honda S, et al. Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp Rheumatol. 2003;21:343–346.
17. Okuda Y, Takasugi K, Oyama T, et al. Intractable diarrhoea associated with secondary amyloidosis in rheumatoid arthritis. Ann Rheum Dis. 1997;56:535–541.
18. Kuroda T, Tanabe N, Harada T, et al. Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis. Clin Rheumatol. 2006;25:498–505.
19. Kuroda T, Tanabe N, Sato H, et al. Outcome of patients with reactive amyloidosis associated with rheumatoid arthritis in dialysis treatment. Rheumatol Int. 2006;26:1147–1153.
20. Ueno T, Takeda K, Nagata M., Remission of proteinuria and preservation of renal function in patients with renal AA amyloidosis secondary to rheumatoid arthritis. Nephrol Dial Transplant. 2012;27:633–639.
21. Osawa Y, Kawamura K, Kondo D, et al. Renal function at the time of renal biopsy as a predictor of prognosis in patients with primary AL-amyloidosis. Clin Exp Nephrol. 2004;8:127–133.
22. Bergesio F, Ciciani AM, Manganaro M, et al. Immunopathology group of the Italian society of nephrology. Renal involvement in systemic amyloidosis:an Italian collaborative study on survival and renal outcome. Nephrol Dial Transplant. 2008;23:941–951.
23. Dikman SH, Churg J, Kahn T., Morphologic and clinical correlates in renal amyloidosis. Hum Pathol. 1981;12:160–169.
24. Nolting SF, Campbell WG., Jr.Subepithelial argyrophilic spicular structures in renal amyloidosis–an aid in diagnosis. Pathogenic Considerations. Hum Pathol. 1981;12:724–734.
25. Nakano M, Ueno M, Nishi S, et al. Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis. Clin Nephrol. 1998;50:154–160.
26. Nakamoto Y, Hamanaka S, Akihama T, et al. Renal involvement patterns of amyloid nephropathy:a comparison with diabetic nephropathy. Clin Nephrol. 1984;22:188–194.
27. Shiiki H, Shimokama T, Yoshikawa Y, et al. Perimembranous-type renal amyloidosis:a peculiar form of AL amyloidosis. Nephron. 1989;53:27–32.
28. Nishi S, Alchi B, Imai N, et al. New advances in renal amyloidosis. Clin Exp Nephrol. 2008;12:93–101.